Lithium addition to a tricyclic antidepressant results in optimal efficacy.
Birkenhäger
T K
TK
Van Den Broek
W W
WW
D000928:Antidepressive Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D004351:Drug Resistance; D004357:Drug Synergism; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D018020:Lithium Compounds / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D016666:Fluvoxamine; D007099:Imipramine; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors